Literature DB >> 30071135

Associations between interleukin gene polymorphisms and the risk of gastric cancer: A meta-analysis.

Yunxia Liu1, Yefeng Xu1, Yiqing Wang1, Yongwei Yao1, Jiewen Yang1.   

Abstract

Recently, the roles of interleukin-2 (IL-2), IL-4, IL-6 and IL-8 gene polymorphisms in gastric cancer (GC) have been studied extensively, with conflicting results. Therefore, we conducted the present meta-analyses to better elucidate the roles of interleukin gene polymorphisms in GC. Eligible articles were searched in PubMed, MEDLINE, Embase, Web of Science and CNKI. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to detect any potential association between interleukin gene polymorphisms and the risk of GC. A total of 63 case-control studies was finally included in our analyses. Significant associations with the risk of GC were detected for the IL-6 rs1800796 and IL-8 rs4073 polymorphisms in overall analyses. Further subgroup analyses based on ethnicities of participants revealed that the IL-4 rs2243250, IL-6 rs1800796 and IL-8 rs4073 polymorphisms were significantly associated with the risk of GC in Asians. Moreover, IL-8 rs4073 polymorphism was also significantly associated with the risk of GC in Africans. In conclusion, our findings suggested that IL-4 rs2243250, IL-6 rs1800796 and IL-8 rs4073 polymorphisms may serve as genetic biomarkers of GC.
© 2018 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  gastric cancer; gene polymorphisms; interleukin; meta-analysis

Mesh:

Substances:

Year:  2018        PMID: 30071135     DOI: 10.1111/1440-1681.13021

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  6 in total

1.  Polymorphisms PSCA rs2294008, IL-4 rs2243250 and MUC1 rs4072037 are associated with gastric cancer in a high risk population.

Authors:  Patricio Gonzalez-Hormazabal; Rocío Retamales-Ortega; Maher Musleh; Marco Bustamante; Juan Stambuk; Raul Pisano; Hector Valladares; Enrique Lanzarini; Hector Chiong; Jose Suazo; Luis A Quiñones; Nelson M Varela; V Gonzalo Castro; Lilian Jara; Ricardo A Verdugo; Zoltan Berger
Journal:  Mol Biol Rep       Date:  2020-10-31       Impact factor: 2.316

2.  Preliminary analysis of single-nucleotide polymorphisms in IL-10, IL-4, and IL-4Rα genes and profile of circulating cytokines in patients with gastric Cancer.

Authors:  Denny Miley Cárdenas; Angie Carolina Sánchez; Daris Angélica Rosas; Esmeralda Rivero; Massiel Dayana Paparoni; Mildred Andreína Cruz; Yeicy Paola Suárez; Nestor Fabián Galvis
Journal:  BMC Gastroenterol       Date:  2018-12-10       Impact factor: 3.067

3.  Associations of tumor necrosis factor-α polymorphisms with the risk of colorectal cancer: a meta-analysis.

Authors:  Xue Huang; Shanyu Qin; Yongru Liu; Lin Tao; Haixing Jiang
Journal:  Biosci Rep       Date:  2019-01-11       Impact factor: 3.840

Review 4.  Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions.

Authors:  Anca Negovan; Mihaela Iancu; Emőke Fülöp; Claudia Bănescu
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

Review 5.  Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer.

Authors:  Xujun Song; Benno Traub; Jingwei Shi; Marko Kornmann
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

6.  Apatinib inhibits gastric carcinoma development by regulating the expression levels of IL-17 via the Bax/Bcl-2 signaling pathway.

Authors:  Tianxi Wang; Jun Zhang; Lihong Cui
Journal:  Exp Ther Med       Date:  2021-04-19       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.